
Alexion Pharmaceuticals, Inc. ALXN
Alexion Pharmaceuticals, Inc. DPO Ratio 2011-2026 | ALXN
Annual DPO Ratio Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 78.2 | 68.5 | 72.6 | 56.9 | 90.5 | 89.8 | 92.4 | 44.4 | 108 | 62.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 108 | 44.4 | 76.4 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.01 | 3.79 % | $ 233 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 11.86 | 2.24 % | $ 781 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Certara
CERT
|
10.2 | $ 8.81 | -0.56 % | $ 1.41 B | ||
|
Celldex Therapeutics
CLDX
|
6.17 K | $ 27.16 | 2.76 % | $ 1.75 M | ||
|
Cellectis S.A.
CLLS
|
975 | $ 4.84 | 1.26 % | $ 116 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 26.78 | -0.81 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.61 | 0.63 % | $ 141 M | ||
|
CorMedix
CRMD
|
216 K | $ 11.63 | -6.81 % | $ 592 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
29.9 | $ 567.93 | -0.73 % | $ 43 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.6 | 1.96 % | $ 16.3 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 91.93 | -0.63 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M |